Sarepta Therapeutics, Inc.
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 1,686 | 0.0% | 78,337 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 1,611 | 0.0% | 83,607 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 1,447 | 0.0% | 84,640 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 5,372 | 0.0% | 84,170 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 10,234 | 0.0% | 84,170 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 10,519 | 0.0% | 84,230 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 13,566 | 0.0% | 85,860 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 12,284 | 0.0% | 89,127 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 8,908 | 0.0% | 92,380 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 11,159 | 0.0% | 92,059 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 10,527 | 0.0% | 91,919 | 6/30/2023 |
| 2023 Q1 | 6/14/2023 | 12,284 | 0.0% | 89,127 | 3/31/2023 |
| 2022 Q4 | 6/14/2023 | 11,549 | 0.0% | 89,127 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 9,969 | 0.0% | 90,187 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 6,975 | 0.0% | 93,047 | 6/30/2022 |
| 2022 Q1 | 5/6/2022 | 7,746 | 0.0% | 99,156 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 8,929 | 0.0% | 99,159 | 12/31/2021 |
| 2021 Q3 | 11/8/2021 | 9,192 | 0.0% | 99,399 | 9/30/2021 |
| 2021 Q2 | 8/10/2021 | 7,851 | 0.0% | 100,993 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 7,642 | 0.0% | 102,537 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 17,860 | 0.0% | 104,757 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 14,142 | 0.0% | 100,702 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 16,033 | 0.0% | 99,992 | 6/30/2020 |
| 2020 Q1 | 5/5/2020 | 9,514 | 0.0% | 97,265 | 3/31/2020 |
| 2019 Q4 | 2/3/2020 | 12,505 | 0.0% | 96,911 | 12/31/2019 |
| 2014 Q2 | 8/7/2014 | 1,175 | 0.0% | 39,434 | 6/30/2014 |
| 2014 Q1 | 4/24/2014 | 864 | 0.0% | 35,962 | 3/31/2014 |
| 2013 Q4 | 2/5/2014 | 733 | 0.0% | 35,962 | 12/31/2013 |